SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Reents Scott T – ‘3’ for 6/28/22 re: AbbVie Inc.

On:  Friday, 7/8/22, at 1:11pm ET   ·   For:  6/28/22   ·   As:  Officer   ·   Accession #:  1415889-22-7553   ·   File #:  1-35565

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/08/22  Reents Scott T                    3          Officer     2:14K  AbbVie Inc.                       SEC Connect

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML     11K 
                Securities by an Insider --                                      
                form3-07082022_100701.xml/2.6                                    
 2: EX-24       Power of Attorney                                   HTML      7K 


‘3’   —   Initial Statement of Beneficial Ownership of Securities by an Insider — form3-07082022_100701.xml/2.6




        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider — form3-07082022_100701.xml/2.6
 
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Reents Scott T

(Last)(First)(Middle)
1 NORTH WAUKEGA

(Street)
NORTH CHICAGOIL60064

(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
6/28/22
3. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
XOfficer (give title below) Other (specify below)
SVP, Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 par value809D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (Right to buy) 2/16/18 (1) 2/15/28Common Stock14,14061.36D
Option (Right to buy) 2/15/19 (2) 2/14/28Common Stock11,810114.36D
Option (Right to buy) 2/21/20 (3) 2/20/29Common Stock19,47079.02D
Option (Right to buy) 2/20/21 (4) 2/19/30Common Stock28,64193.5D
Option (Right to buy) 2/18/22 (5) 2/17/31Common Stock15,527105.92D
Option (Right to buy) 2/17/23 (6) 2/16/32Common Stock11,383144.54D
Explanation of Responses:
(1)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 4,714 shares on 2/16/18, as to 4,713 shares on 2/16/19 and as to 4,713 shares on 2/16/20.
(2)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 3,936 shares on 2/15/19, as to 3,937 shares on 2/15/20 and as to 3,937 shares on 2/15/21.
(3)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 6,490 shares on 2/21/20, as to 6,490 shares on 2/21/21 and as to 6,490 shares on 2/21/22.
(4)  Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 9,547 shares on 2/20/21, as to 9,547 shares on 2/20/22 and will become exercisable as to 9,547 shares on 2/20/23.
(5)  Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 5,176 shares on 2/18/22, and will become exercisable as to 5,176 shares on 2/18/23 and as to 5,175 shares on 2/18/24.
(6)  Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 3,794 shares on 2/17/23, as to 3,794 shares on 2/17/24 and as to 3,795 shares on 2/17/25.
Steven L. Scrogham, attorney-in-fact for Scott T. Reents 7/8/22
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Top
Filing Submission 0001415889-22-007553   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:41:45.1am ET